Venlafaxine Hydrochloride

盐酸文拉法辛

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameVenlafaxine Hydrochloride
Drug Alias Name盐酸维拉法辛venlafaxinumvenlafaxina盐酸文拉法新Venlafaxine EA +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderPhobia, Social +[15] 
Global Approved IndicationsDepressive DisorderDepression
Approved Indications in ChinaDepression
Original Approved Country/TerritoryUnited States
Original Approved Date1993/12/28
Country/TerritoryCanadaUnited StatesFrance +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWyeth Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUpjohn Us 2 LlcOsmotica Pharmaceutical CorpViatris Pharmaceuticals Japan Inc +[8] 
Inactive CompaniesWyeth LlcViatrisActavis Inc +[11] 
Active IndicationsDepressive Disorder, MajorDepressive DisorderPhobia, Social +[9] 
Inactive IndicationsMarijuana AbuseCocaine-Related DisordersAlcohol-Related Disorders +[6] 

Other Information

ATC CodeN06AX16
Related LinksWikipediaDrugBankKEGG